<VariationArchive VariationID="1072850" VariationName="NM_001386140.1(MTTP):c.419dup (p.Asn140fs)" VariationType="Duplication" Accession="VCV001072850" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-19" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1060098" VariationID="1072850">
      <GeneList>
        <Gene Symbol="MTTP" FullName="microsomal triglyceride transfer protein" GeneID="4547" HGNC_ID="HGNC:7467" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="99564130" stop="99623997" display_start="99564130" display_stop="99623997" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="100485239" stop="100545153" display_start="100485239" display_stop="100545153" Strand="+" />
          </Location>
          <OMIM>157147</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001386140.1(MTTP):c.419dup (p.Asn140fs)</Name>
      <CanonicalSPDI>NC_000004.12:99589664:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="99589664" stop="99589665" display_start="99589664" display_stop="99589665" variantLength="1" positionVCF="99589664" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="100510821" stop="100510822" display_start="100510821" display_stop="100510822" variantLength="1" positionVCF="100510821" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>N140fs</ProteinChange>
      <ProteinChange>N57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.100510825dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.100510825dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.99589668dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.99589668dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011469.1" sequenceAccession="NG_011469" sequenceVersion="1" change="g.30586dup">
            <Expression>NG_011469.1:g.30586dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000253.4" sequenceAccession="NM_000253" sequenceVersion="4" change="c.419dup">
            <Expression>NM_000253.4:c.419dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000244.2" sequenceAccession="NP_000244" sequenceVersion="2" change="p.Asn140fs">
            <Expression>NP_000244.2:p.Asn140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300785.2" sequenceAccession="NM_001300785" sequenceVersion="2" change="c.170dup">
            <Expression>NM_001300785.2:c.170dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287714.2" sequenceAccession="NP_001287714" sequenceVersion="2" change="p.Asn57fs">
            <Expression>NP_001287714.2:p.Asn57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386140.1" sequenceAccession="NM_001386140" sequenceVersion="1" change="c.419dup" MANESelect="true">
            <Expression>NM_001386140.1:c.419dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373069.1" sequenceAccession="NP_001373069" sequenceVersion="1" change="p.Asn140fs">
            <Expression>NP_001373069.1:p.Asn140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000253.3" sequenceAccession="NM_000253" sequenceVersion="3" change="c.419dupA">
            <Expression>NM_000253.3:c.419dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="762901763" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001386140.1(MTTP):c.419dup (p.Asn140fs) AND not provided" Accession="RCV001385678" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001386140.1(MTTP):c.419dup (p.Asn140fs) AND Abetalipoproteinaemia" Accession="RCV001831391" Version="4">
        <ClassifiedConditionList TraitSetID="3929">
          <ClassifiedCondition DB="MedGen" ID="C0000744">Abetalipoproteinaemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-23" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001386140.1(MTTP):c.419dup (p.Asn140fs) AND MTTP-related disorder" Accession="RCV003405634" Version="4">
        <ClassifiedConditionList TraitSetID="90321">
          <ClassifiedCondition>MTTP-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-25" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10946006</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8533758</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9671739</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="90321" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70786" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MTTP-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">MTTP-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3929" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Abetalipoproteinemia</ElementValue>
                <XRef ID="HP:0008181" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008692" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bassen Kornzweig syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microsomal triglyceride transfer protein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microsomal-triglyceride transfer protein deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Low-density beta lipoprotein deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abetalipoproteinemia neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Apolipoprotein B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Betalipoprotein deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital betalipoprotein deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MTP DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="200100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Abetalipoproteinaemia</ElementValue>
                <XRef ID="Familial+Hypobetalipoproteinemia+%28FHBL%29/2751" DB="Genetic Alliance" />
                <XRef ID="190787008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ABL</ElementValue>
                <XRef Type="MIM" ID="200100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. Hematologic manifestations may include acanthocytosis (irregularly spiculated erythrocytes), anemia, reticulocytosis, and hemolysis with resultant hyperbilirubinemia. Malabsorption of fat-soluble vitamins (A, D, E, and K) can result in an increased international normalized ratio (INR). Untreated individuals may develop atypical pigmentation of the retina that may present with progressive loss of night vision and/or color vision in adulthood. Neuromuscular findings in untreated individuals including progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle weakness; dysarthria; and ataxia typically manifest in the first or second decades of life.</Attribute>
                <XRef ID="NBK532447" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5" />
                <XRef ID="5" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <URL>http://www.nature.com/ejhg/journal/vaop/ncurrent/full/ejhg201230a.html</URL>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30358967</ID>
                <ID Source="BookShelf">NBK532447</ID>
              </Citation>
              <XRef ID="14" DB="Orphanet" />
              <XRef ID="C0000744" DB="MedGen" />
              <XRef ID="MONDO:0008692" DB="MONDO" />
              <XRef Type="MIM" ID="200100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008181" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4074451" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000253.4:c.419dup|Abetalipoproteinemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002082412" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000253.4:c.419dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Abetalipoproteinemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7081312" SubmissionDate="2023-02-06" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000253.3:c.419dupA|MedGen:C0000744" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003800693" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8533758</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10946006</ID>
          </Citation>
          <Comment>Variant summary: MTTP c.419dupA (p.Asn140LysfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2.4e-05 in 251188 control chromosomes (gnomAD). c.419dupA has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Abetalipoproteinaemia (Bassen-Kornzweig Syndrome) (e.g. Narcisi_1995, Ohashi_2000). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence demonstrating that a truncation downstream from the variant results in &lt;5% of normal activity, suggesting this variant would likely also severely impact protein function (e.g. Narcisi_1995). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTTP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000253.3:c.419dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0000744" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12766635</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7696657" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="22155604|MTTP-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004113618" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MTTP c.419dupA variant is predicted to result in a frameshift and premature protein termination (p.Asn140Lysfs*2). This variant has been reported in the homozygous and compound heterozygous states in multiple individuals with abetalipoproteinaemia (Narcisi TME et al 1995. PubMed ID: 8533758; Ohashi K et al 2000. PubMed ID: 10946006). This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-100510821-C-CA). Frameshift variants in MTTP are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTTP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000253.3:c.419dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MTTP-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3111270" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4850713|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585624" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8533758</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9671739</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8533758</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn140Lysfs*2) in the MTTP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTTP are known to be pathogenic (PMID: 8533758, 9671739). This variant is present in population databases (rs762901763, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with abetalipoproteinemia (PMID: 8533758). ClinVar contains an entry for this variant (Variation ID: 1072850). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTTP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.100510821_100510822insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7081312" TraitType="Disease" MappingType="XRef" MappingValue="C0000744" MappingRef="MedGen">
        <MedGen CUI="C0000744" Name="Abetalipoproteinaemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4074451" TraitType="Disease" MappingType="Name" MappingValue="Abetalipoproteinemia" MappingRef="Preferred">
        <MedGen CUI="C0000744" Name="Abetalipoproteinaemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3111270" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7696657" TraitType="Disease" MappingType="Name" MappingValue="MTTP-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="MTTP-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

